Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-13-222590
Filing Date
2013-05-15
Accepted
2013-05-15 16:51:07
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A d507513ds1a.htm S-1/A 905989
2 EX-1.1 d507513dex11.htm EX-1.1 95664
3 EX-4.1 d507513dex41.htm EX-4.1 138928
4 EX-4.3 d507513dex43.htm EX-4.3 72504
5 EX-5.1 d507513dex51.htm EX-5.1 9000
6 EX-23.2 d507513dex232.htm EX-23.2 2548
7 GRAPHIC g507513g27z94.jpg GRAPHIC 23726
8 GRAPHIC g507513g44a41.jpg GRAPHIC 32201
9 GRAPHIC g507513g78o00.jpg GRAPHIC 27903
10 GRAPHIC g507513g90q05.jpg GRAPHIC 17579
  Complete submission text file 0001193125-13-222590.txt   1366118
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-187508 | Film No.: 13848024
SIC: 2835 In Vitro & In Vivo Diagnostic Substances